- **HOPE Therapeutics, Inc.**, a subsidiary of NRx Pharmaceuticals, Inc., has **acquired a strategic interest in Cohen and Associates, LLC**, incorporating it into the HOPE Network.  **[1270436_77ecc0e513034a158dc340224748df65_1]** 
- **Dr. Rebecca Cohen**, founder of Cohen and Associates, LLC and an expert in interventional psychiatry and Transcranial Magnetic Stimulation (TMS), has been appointed as **Medical Director** for HOPE's Florida locations.  **[1270436_77ecc0e513034a158dc340224748df65_0]** **[1270436_77ecc0e513034a158dc340224748df65_1]** 
- The acquisition is **expected to be accretive to HOPE Therapeutics revenue and EBITDA**, with immediate expansion planned in Western Florida and Palm Beach.  **[1270436_77ecc0e513034a158dc340224748df65_0]**

HOPE Therapeutics Acquires Cohen & Associates, LLC and Appoints Dr. Rebecca Cohen as Medical Director

- Critical Metals Corp. (CRML) announced on **October 6, 2025**, a Private Investment in Public Equity (PIPE) transaction to raise **$35,000,000** in gross proceeds from a fundamental institutional investor.  **[1270436_b9829d5034794cd585a81e3624715c13_0]** 
- The company intends to use the net proceeds to help fund the development of its **4.7 billion metric ton rare earth deposit, Tanbreez, in Greenland**.  **[1270436_b9829d5034794cd585a81e3624715c13_0]** 
- Under the terms, Critical Metals Corp. will issue **5 million ordinary shares** and warrants to purchase **10 million ordinary shares** at a strike price of **$7.00 per share**, with a 6-year expiration.  **[1270436_b9829d5034794cd585a81e3624715c13_0]**

Critical Metals Corp. Secures $35 Million PIPE Financing

- Predictive Discovery Limited (PDI) and Robex Resources Inc. (Robex) have entered into a definitive agreement for a **merger of equals**, with PDI acquiring all outstanding Robex Shares.  **[1270436_a4231aa424d94f1290f107b9ca3a2990_1]** 
- Robex shareholders will receive **8.667 PDI Shares** for each Robex Share, leading to existing PDI shareholders owning approximately **51%** and former Robex shareholders approximately **49%** of the combined company on a fully diluted in-the-money basis.  **[1270436_a4231aa424d94f1290f107b9ca3a2990_1]** 
- The combined company is projected to exceed **400kozpa Au** production by **2029**, with combined Mineral Resources of approximately **9.5Moz Au** and Ore Reserves of approximately **4.5Moz Au**.  **[1270436_a4231aa424d94f1290f107b9ca3a2990_0]** **[1270436_a4231aa424d94f1290f107b9ca3a2990_2]** 
- With an implied market capitalization of **A$2,350 million (C$2,168 million)**, the transaction aims to create West Africa's next mid-tier gold producer and is expected to close in **December 2025 or early 2026**.  **[1270436_a4231aa424d94f1290f107b9ca3a2990_0]** **[1270436_a4231aa424d94f1290f107b9ca3a2990_1]** **[1270436_a4231aa424d94f1290f107b9ca3a2990_2]**

Cohen & Co (COHN)